Systane® is an artificial tear that contains a polymer, HP-Guar, which has unique gelling properties for enhanced efficacy. When Systane® is exposed to the eye, it forms a soft gel-like consistency that prolongs protection of the eye's surface by keeping the eye's tear film moist.
Systane® provides relief for most dry eye symptoms including dryness, burning and foreign body sensation.
If the solution should become discolored or cloudy, it would be apparent through the translucent bottle. Contact us and include your name, address, daytime phone number, and the product lot code. We will be glad to send you a replacement.
Systane® contains the preservative, POLYQUAD®. POLYQUAD® is proven to be safe and gentle. Millions of patients worldwide have used POLYQUAD®. It is considered nonsensitizing and one of the gentlest preservatives on the market.
The unique technology of Systane® is based on a proprietary polymer system which allows it to form a soft gel-like layer over the eye's surface. This results in a more stable tear layer, enhanced moisture retention, and a smooth protective coating that shields eye tissues from the effects of drying.
Apply one to two drops of Systane® Unit-Dose Preservative Free in your eyes. Wait approximately 10 minutes before inserting your contact lenses. Clinical studies show improved contact lens wear comfort when Systane® Unit-Dose Preservative Free is used before and after wearing contact lenses. Systane® Unit-Dose Preservative Free has not been clinically proven for use when contact lenses are in the eye.
Access the clinical trial of interest in the Trial in Recruitment section, which will link you to the trial information on the U.S. Government Clinical Trial Website. This site will provide you with the contact information, trial number, and eligibility requirements needed to enroll in a study.
Airport security regulations currently consider contact lens solutions, saline solution, and rewetting drops as "over-the-counter medications" that can be carried on the plane if they meet the following inspection criteria. All prescription and over-the-counter medications (liquids, gels, and aerosols) including lubricating jelly, eye drops, and saline solution for medical purposes are permitted. You are not limited in the amount or volume of these items you may bring in your carry-on baggage. BUT if the medically necessary items exceed three ounces or are not contained in a one-quart, zip-top plastic bag, you MUST declare to one of the security officers at the checkpoint for further inspection. For further information and updates on security regulations for the US and other countries that have adopted the Transportation Security Administration (TSA) guidelines, check the TSA Web site. Alcon bottle OPTI-FREE® Express® and OPTI-FREE® RepleniSH® contact lens solutions in a 4 ounce size, which can usually be found in the contact lens solution aisle of most major retailers.
Alcon establishes a product cost to the retailer, and each retailer determines the final price to the consumer. We encourage you to shop and compare retail prices at various retailers and to get the best value.
Alcon does not sell directly to consumers. However, Alcon lens care products can be found at most major retailers, grocery stores and pharmacies worldwide. Please be sure to look in the general eye care section of these stores in order to locate the product.
Alcon does not sell directly to consumers. However, Alcon lens care products can be found at most major retailers, grocery stores and pharmacies. Please be sure to look in the general eye care section of these stores in order to locate the product.
Your eyes are unique and your doctor may recommend additional products or procedures to care for your lenses based upon your individual chemistry or lens wearing schedule. Consult with your eye care professional.
OPTI-FREE® RepleniSH® is a multi-purpose disinfecting formulation that contains a proprietary dual-action reconditioning system. OPTI-FREE® RepleniSH® is specially designed to recondition silicone hydrogel and soft contact lenses. It contains disinfecting agents compatible with all soft contact lenses.
OPTI-FREE® RepleniSH® represents the latest technology in lens care and is clinically proven to improve contact lens comfort in all wearers and extend lens surface moisture retention up to 14 hours. We anticipate that OPTI-FREE® RepleniSH® will eventually phase out OPTI-FREE® Express®.
OPTI-FREE® RepleniSH® is packaged in 12 oz bottles that are filled with 10 oz of solution. The new technology of the OPTI-FREE® RepleniSH® formulation requires manufacturing to produce a 10 oz fill in a 12 oz bottle.
OPTI-FREE® RepleniSH® was cleared by the FDA for use with silicone hydrogels and soft contact lenses. We have not tested the product for use with RGP contact lenses.
To respond to customer requests, Alcon has decided to continue production of Unique-pH® Multi-Purpose Solution in the United States. Plans to continue production for distribution in additional countries is not yet determined. Unique-pH® is available to US residents through www.Amazon.com and www.Drugstore.com. Unique-pH® Multi-Purpose Solution is a cleaning, conditioning, and disinfecting product designed for gas permeable lenses. Unique-pH® contains a revolutionary polymer system that changes solution characteristics based on tear pH. The product is dispensed from the bottle as a low viscosity solution for ease of use in cleaning and conditioning gas perm lenses. The product changes to a thicker viscosity upon lens insertion for enhanced comfort during lens wear while maintaining visual acuity. Product questions should be directed to Alcon's Customer Service Department at 800.451.3937 or fax 800.777.2799. All orders should be placed through www.Amazon.com or www.Drugstore.com.
ICAPS® Plus tablets do not have the time-release feature available in other ICAPS® products. Therefore, breaking these tablets does not impact the effectiveness of these tablets. However, other time-release formulations should not be broken.
The cotton has been removed from all ICAPS® bottles because the ICAPS® vitamins are triple coated so the bottle does not require cotton. The bottle neck has also been shortened, thus reducing the risk of tablets moving around and breaking.
The red color in ICAPS® AREDS was chosen as an esthetically pleasing color that is safe. The red in AREDS is FD&C Red # 40 Lake. This colorant is certified and tested, approved by the FDA, and is found abundantly in food, drug and cosmetic products.
The yellow color in ICAPS® LZ is from riboflavin, vitamin B2. This colorant is certified and tested, and is found abundantly in food, drug and cosmetic products.
ICAPS Original has the same formulation as ICAPS® Plus. ICAPS® TR is no longer available. ICAPS® Plus is a time-release, high-potency antioxidant formula that contains Lutein and Zeaxanthin.
The Alcon Patient Assistance Program provides assistance to those in need through physicians and hospitals. For more information on guidelines and the process for requesting assistance, please see Patient Assistance.
If you are dissatisfied with an Alcon product for any reason please contact us and include your name, address, daytime phone number and the product lot code on the product label. We will work with you and/or your doctor to get you a replacement product.
Alcon's products are filled by machines, and the procedures are carefully monitored during the production process. However, on rare occasions, it is possible for an incident such as low fill to occur. Contact us with your name, address, daytime phone number and the product lot code on the product label, and we will respond to your inquiry.
If you believe that an Alcon product that you own has been recalled, you may contact us with the product lot code on the label. We will be happy to inform you of the status of that lot code and if the product has been recalled, provide you a replacement.
The Alcon Patient Assistance Program provides assistance to those in need through physicians and hospitals. For more information on guidelines and the process for requesting assistance, please see Patient Assistance.
Unparalleled value, that's why. Alcon Field Engineers work exclusively with Alcon equipment. They are trained in surgical and clinical environments, as well as advanced technical issues. By providing peak instrumentation performance, the Alcon Partners in Patient Care Program lets you focus on your patients. Partners in Patient Care maintains your instrumentation properly so that it meets the safety requirements of all relevant regulatory agencies. In-service training puts your patients in the care of well-trained staff. Additionally, Partners In Patient Care means less patient waiting and rescheduling. Why? Because it helps minimize equipment downtime, so you can be more effective.
Yes. Unexpected service costs are virtually eliminated. In addition, budgeting is easier and more accurate with the Alcon Partners in Patient Care Program fixed annual cost. Multiple year, multiple machine agreements can be a part of your program. This means you save because the cost will be fixed for the term of the agreement. Key account pricing and flexible financing is available.
Yes. Regular maintenance of equipment helps avoid untimely failure and the time-consuming process of rescheduling patients. Staff productivity is also enhanced through in-service training. Finally, your program requires only one purchase order.
No other service can match the benefits of our program! Alcon Field Engineers, trained in surgical and clinical applications, can easily identify downtime or operator error. For example, other services may not have the expertise or equipment necessary to fix or calibrate Alcon instrumentation. Alcon uses genuine factory parts and assemblies that are readily available to Alcon Field Engineers. You purchase Alcon equipment because of its excellence and value added benefits --- enroll in the Alcon Partners in Patient Care Program for the same reasons.
Alcon Field Engineers --- Alcon Field Engineers know and comply with our strict manufacturing guidelines to make certain that equipment is performing to specification. They work only on Alcon equipment, and they keep a comprehensive service record of your equipment history.
Emergency Service --- On-site emergency service reduces downtime and minimizes surgery schedule interruption.
Scheduled Preventive Maintenance --- An on-site calibration, in-depth evaluation and component cleaning help avoid unanticipated downtime.
System Upgrades --- Many software and hardware refinements that extend the life of your equipment are included at no additional charge.
In-Service Training --- On-site training for your staff to help improve efficiency and confidence.
Parts and labor --- All parts, travel and labor are included, for one fixed cost. Please refer to your customized Alcon Partners in Patient Care Program proposal for an exact listing of the benefits you’ll receive.
Our goal is to get your instrumentation on-line before your next surgery date so you and your patients are not affected. To meet that goal, the most frequently needed replacement parts are carried by your Alcon Field Engineer, with others available by overnight delivery.
Certainly. The Alcon Partners in Patient Care Program delivers training for your staff whenever it's needed. Just call to schedule an appointment or advise your Alcon representative.
Yes. Our Technical Support Specialists are available Monday - Friday, 6:00 am to 8:00 pm Eastern Standard Time, to provide answers to all your technical questions. The toll-free number is 1-800-TEC-SVCS (1-800-832-7827 - EXT 2).
We develop, manufacture and market ophthalmic pharmaceuticals, ophthalmic surgical equipment and devices, contact lens care products and other consumer eye care products that treat diseases and conditions of the eye. See Alcon At-a-Glance for more information
We are incorporated in Hünenberg, Switzerland and our Corporate Office is located at Bösch 69, P.O. Box 62, 6331, Hünenberg, Switzerland. Our principal United States offices are located at 6201 South Freeway, Fort Worth, Texas 76134-2099, U.S.A.
We offer a wide variety of high quality products in the surgical, pharmaceutical and consumer eye care markets. Please visit our Eye Health Products section.
The next Annual General Meeting will be held on 5 May 2009. The last Annual General Meeting of shareholders was held on 6 May 2008 in Zug, Switzerland.
On 6 May 2008, Alcon shareholders approved a dividend of 2.63 Swiss francs per share, for shareholders of record on 12 May 2008. For shareholders who did not elect to receive Swiss francs, the dividend was paid at the US dollar equivalent of US$2.5347 per share. A tax of 35% was withheld and remitted to Swiss tax authorities, for a net payment of US$1.6476 per share.
If you were a registered shareholder on 12 May 2008 (your shares were in the form of a stock certificate), your dividend was mailed to you or paid by direct deposit on 22 May 2008. If your shares were held through a brokerage account, your dividend was sent to your broker on your behalf.
If you are a US qualified taxpayer, you may be eligible to reclaim a portion of the tax. If you are a registered shareholder (you have a stock certificate), you can participate in a tax reclamation filing. In order to participate, complete and return the consent form provided by Globe Tax. If your shares are held through a brokerage account, your broker must elect to participate in the tax reclamation. Your refund will take several months to be processed and received. If you need an additional copy of the consent form or have additional questions please contact us.
Nestlé acquired Alcon in 1978 and retained 100 percent ownership until March 2002, when the company conducted an initial public offering (IPO) of about 25 percent of Alcon’s shares with Nestlé retaining ownership of the balance with Nestlé retaining ownership of the balance. In July 2008 Nestlé sold about 74 million shares to Novartis AG, which now owns approximately 24.8% of Alcon issued and outstanding shares. Nestlé S.A. remains Alcon's primary shareholder with 52 percent of Alcon's issued capital. Alcon operates with a great deal of independence from the Nestlé organization. For more, read the press release regarding the Nestlé-Novartis deal or read the frequently asked question "What is your relationship with Novartis?"
Nestlé S.A. and Novartis AG entered into an agreement in April 2008 for Novartis to buy approximately 74 million shares of Alcon stock owned by Nestlé at a price of $143.18. With the completion of the first step transaction in July 2008, Nestlé remains Alcon’s majority shareholder with ownership of about 52 percent and Novartis owns a minority interest at 24.85 percent. The two companies also announced a second phase of the agreement which could allow Novartis to purchase the remaining Nestlé shares and become the majority owner of Alcon, with a stake of approximately 77 percent. The second phase cannot begin until 1 January 2010 and may extend through 31 July 2011. There are no requirements in the agreement for Novartis to acquire the publicly traded shares of Alcon.
Alcon shares were priced on 20 March 2002 at US$33 per share, and started trading on the New York Stock Exchange (NYSE) under ticker symbol ACL on 21 March 2002.
Cary Rayment, Chairman, President and CEO, Alcon, Inc. 1 Kevin J. Buehler, Senior Vice President, Global Markets and Chief Marketing Officer, Alcon, Inc. 2 Richard J. Croarkin, Senior Vice President, Chief Financial Officer and Corporate Strategy1 Ed McGough, Senior Vice President, Global Manufacturing and Technical Operations 2 Elaine E. Whitbeck, Senior Vice President, Chief Legal Officer, General Counsel and Corporate Secretary2 (1) Alcon, Inc. and Alcon Laboratories, Inc. (2) Alcon Laboratories, Inc.
Cary Rayment (Chairman); Dr. Werner Bauer; Francisco Castañer; Paul Bulcke; Lodewijk J.R. de Vink; Gerhard N. Mayr; Thomas G. Plaskett; James Singh; Daniel Vasella, M.D. Read more about our Board of Directors.
